apatinib and Tracheal-Neoplasms

apatinib has been researched along with Tracheal-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for apatinib and Tracheal-Neoplasms

Article	Year
Case report of apatinib mesylate treatment in rare advanced tracheal adenoid cystic carcinoma. Thoracic cancer, 2017, Volume: 8, Issue:6 A 57-year-old man was admitted to our department 10 years ago, diagnosed with tracheal adenoid cystic carcinoma. After discontinuing chemotherapy and radiotherapy, the disease recurred in December 2016. Apatinib mesylate (500 mg/day) was administered and computed tomography revealed that his symptoms were significantly relieved. Treatment with apatinib mesylate represents a novel method of treatment for tracheal adenoid cystic carcinoma. Topics: Antineoplastic Agents; Carcinoma, Adenoid Cystic; Humans; Male; Middle Aged; Pyridines; Tomography, X-Ray Computed; Tracheal Neoplasms; Treatment Outcome	2017

Article

Year

Case report of apatinib mesylate treatment in rare advanced tracheal adenoid cystic carcinoma.

Thoracic cancer, 2017, Volume: 8, Issue:6

A 57-year-old man was admitted to our department 10 years ago, diagnosed with tracheal adenoid cystic carcinoma. After discontinuing chemotherapy and radiotherapy, the disease recurred in December 2016. Apatinib mesylate (500 mg/day) was administered and computed tomography revealed that his symptoms were significantly relieved. Treatment with apatinib mesylate represents a novel method of treatment for tracheal adenoid cystic carcinoma.

Topics: Antineoplastic Agents; Carcinoma, Adenoid Cystic; Humans; Male; Middle Aged; Pyridines; Tomography, X-Ray Computed; Tracheal Neoplasms; Treatment Outcome

2017